Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-02 | Myron Z. Holubiak, 66, has been a director of the Company since March 2005 and was appointed Chairman of the Board of the Company on April 18, 2012. ... Mr. Holubiak is the former President of Roche Laboratories, Inc. ... The Company has standing Audit, Governance and Nominating, Management Development and Compensation, and Corporate Strategy Committees. ... Audit Committee: Myron Z. Holubiak ... Corporate Strategy Committee: Myron Z. Holubiak ... Compensation Committee: Myron Z. Holubiak ... Director Compensation Table: Myron Z. Holubiak total compensation $162,700. |
| 2014-03-31 | Myron Z. Holubiak, 67, has been a director of the Company since March 2005 and was appointed Chairman of the Board on April 18, 2012. ... The table below sets forth all compensation earned by the Company’s non-employee directors in 2013. ... Myron Z. Holubiak 100,000 141,000 241,000 |
| 2015-04-08 | Myron Z. Holubiak, 68, has been a director of the Company since March 2005 and was appointed Chairman of the Board on April 18, 2012. Prior to being appointed a director of the Company he had served as a director of Chronimed since September 2002. Mr. Holubiak held many executive, operational and marketing and sales positions with Roche Laboratories, Inc. over a career that spanned 18 years, including serving as its President from December 1998 to August 2001. Currently, Mr. Holubiak is the President and Chief Executive Officer of Leonard Meron Biosciences, a late stage drug development company focused on critical care. Mr. Holubiak is also a member of the board of directors of 1-800-Doctors, Inc., a medical referral company that provides consumers with access to physicians and hospitals. Since July 2010, Mr. Holubiak has been a lead independent director of Assembly Biosciences (formerly Ventrus BioSciences, Inc.), an early stage biotechnology development company. From 2012 to 2014, Mr. Holubiak was a member of the board of directors of IntelliCell Biosciences, Inc. Mr. Holubiak is a lifetime honorary member of the Academy of Managed Care Pharmacy (AMCP), and a Trustee of the AMCP Foundation. We believe his experience in the healthcare industry and managerial background, together with his past experience as a board member of Chronimed (a predecessor of the Company), are particularly relevant to Mr. Holubiaks service on the Board. |
Data sourced from SEC filings. Last updated: 2026-03-05